Session

IBD (Posters)

RISK OF PREVALENT ASTHMA AMONG CHILDREN AFFECTED BY INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED BIRTH COHORT STUDY
RISK OF PREVALENT ASTHMA AMONG CHILDREN AFFECTED BY INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED BIRTH COHORT STUDY

DEEP ENDOSCOPIC ULCERATIONS ARE NOT ASSOCIATED WITH THE NEED FOR SURGERY OR COMPLICATED BEHAVIOR : A POPULATION-BASED STUDY
DEEP ENDOSCOPIC ULCERATIONS ARE NOT ASSOCIATED WITH THE NEED FOR SURGERY OR COMPLICATED BEHAVIOR : A POPULATION-BASED STUDY

HIGHER VS STANDARD ADALIMUMAB INDUCTION AND MAINTENANCE TREATMENT IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: INTEGRATED RESULTS FROM THE PHASE 3 SERENE-UC STUDY
HIGHER VS STANDARD ADALIMUMAB INDUCTION AND MAINTENANCE TREATMENT IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: INTEGRATED RESULTS FROM THE PHASE 3 SERENE-UC STUDY

CHARACTERIZATION OF MUCOSAL CYTOKINE PROFILE IN ULCERATIVE COLITIS PATIENTS UNDER CONVENTIONAL AND ANTI-TNF-A TREATMENT
CHARACTERIZATION OF MUCOSAL CYTOKINE PROFILE IN ULCERATIVE COLITIS PATIENTS UNDER CONVENTIONAL AND ANTI-TNF-A TREATMENT

EMERGING ROLE OF IL-33/ST2 AND GUT MICROBIOTA AXIS IN PREDICTING MUCOSAL AND HISTOLOGICAL RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS
EMERGING ROLE OF IL-33/ST2 AND GUT MICROBIOTA AXIS IN PREDICTING MUCOSAL AND HISTOLOGICAL RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS

SEROLOGICAL BIOMARKERS OF INTERSTITIAL MATRIX AND BASEMENT MEMBRANE REMODELLING CORRELATES THE MODIFIED MAYO ENDOSCOPIC SCORE (MMES) FOR ULCERATIVE COLITIS
SEROLOGICAL BIOMARKERS OF INTERSTITIAL MATRIX AND BASEMENT MEMBRANE REMODELLING CORRELATES THE MODIFIED MAYO ENDOSCOPIC SCORE (MMES) FOR ULCERATIVE COLITIS

BIO-NAIVE CROHN'S DISEASE PATIENTS WITH LONG-STANDING DISEASE BENEFIT FROM USTEKINUMAB TREATMENT: REAL WORLD EXPERIENCE
BIO-NAIVE CROHN'S DISEASE PATIENTS WITH LONG-STANDING DISEASE BENEFIT FROM USTEKINUMAB TREATMENT: REAL WORLD EXPERIENCE

RAC1/PSTAT3 EXPRESSION IN LYMPHOCYTES MAY SERVE AS A PHARMACODYNAMIC MARKER TO OPTIMIZE PERSONALIZED THIOPURINE THERAPY IN IBD PATIENTS
RAC1/PSTAT3 EXPRESSION IN LYMPHOCYTES MAY SERVE AS A PHARMACODYNAMIC MARKER TO OPTIMIZE PERSONALIZED THIOPURINE THERAPY IN IBD PATIENTS

PHYSICAL EXERCISE IS ASSOCIATED WITH BETTER BODY COMPOSITION TRAITS IN YOUNG ADULTS WITH CHILDHOOD-ONSET INFLAMMATORY BOWEL DISEASE
PHYSICAL EXERCISE IS ASSOCIATED WITH BETTER BODY COMPOSITION TRAITS IN YOUNG ADULTS WITH CHILDHOOD-ONSET INFLAMMATORY BOWEL DISEASE

BIOMARKERS OF ELASTIN DEGRADATION IS ASSOCIATED WITH CLINICAL AND BIOCHEMICALLY ACTIVE DISEASE IN CROHN'S DISEASE
BIOMARKERS OF ELASTIN DEGRADATION IS ASSOCIATED WITH CLINICAL AND BIOCHEMICALLY ACTIVE DISEASE IN CROHN'S DISEASE

BIOMARKERS OF EXTRACELLULAR MATRIX REMODELLING ARE ASSOCIATED WITH INTESTINAL FIBROSIS ASSESSED BY MAGNETIC RESONANCE ENTEROGRAPHY AND ACCUMULATED INTESTINAL DAMAGE (LÉMANN INDEX) - THE IBSEN STUDY
BIOMARKERS OF EXTRACELLULAR MATRIX REMODELLING ARE ASSOCIATED WITH INTESTINAL FIBROSIS ASSESSED BY MAGNETIC RESONANCE ENTEROGRAPHY AND ACCUMULATED INTESTINAL DAMAGE (LÉMANN INDEX) - THE IBSEN STUDY

ROLE OF IFN?-ACTIVATED MACROPHAGES IN THE EPITHELIAL MESENCHYMAL TRANSITION IN CROHN'S DISEASE
ROLE OF IFN?-ACTIVATED MACROPHAGES IN THE EPITHELIAL MESENCHYMAL TRANSITION IN CROHN'S DISEASE

EXCLUSIVE ENTERAL NUTRITION OR PREDNISOLONE INDUCTION TREATMENT: CLINICAL AND ENDOSCOPIC EVALUATION OF NEW-ONSET LUMINAL PAEDIATRIC CROHN'S DISEASE
EXCLUSIVE ENTERAL NUTRITION OR PREDNISOLONE INDUCTION TREATMENT: CLINICAL AND ENDOSCOPIC EVALUATION OF NEW-ONSET LUMINAL PAEDIATRIC CROHN'S DISEASE

THE PRESENCE OF CITRATE IN ADALIMUMAB-BASED TREATMENTS CORRELATES WITH THE PERCEPTION OF PAIN AFTER SUBCUTANEOUS INJECTION, IN INFLAMMATORY BOWEL DISEASE PATIENTS
THE PRESENCE OF CITRATE IN ADALIMUMAB-BASED TREATMENTS CORRELATES WITH THE PERCEPTION OF PAIN AFTER SUBCUTANEOUS INJECTION, IN INFLAMMATORY BOWEL DISEASE PATIENTS

ASSESSMENT OF COMORBIDITY AND PHYSICAL CAPACITY AS MARKERS FOR SAFETY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ASSESSMENT OF COMORBIDITY AND PHYSICAL CAPACITY AS MARKERS FOR SAFETY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

WNT1-INDUCIBLE SIGNALING PROTEIN-1 IS ASSOCIATED WITH INTESTINAL FIBROSIS IN CROHN_S DISEASE
WNT1-INDUCIBLE SIGNALING PROTEIN-1 IS ASSOCIATED WITH INTESTINAL FIBROSIS IN CROHN_S DISEASE

CROHN'S DISEASE EXCLUSION DIET INDUCES REMISSION IN ADULTS WITH MILD TO MODERATE CROHN_S DISEASE:PRELIMINARY REPORT FROM A RANDOMISED CONTROLLED TRIAL (CDED-AD TRIAL)
CROHN'S DISEASE EXCLUSION DIET INDUCES REMISSION IN ADULTS WITH MILD TO MODERATE CROHN_S DISEASE:PRELIMINARY REPORT FROM A RANDOMISED CONTROLLED TRIAL (CDED-AD TRIAL)

ANXIETY, DEPRESSION AND ALEXITHYMIC TRAITS IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS: CORRELATIONS WITH CLINICAL SYMPTOMS AND INFLAMMATION INDICES
ANXIETY, DEPRESSION AND ALEXITHYMIC TRAITS IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS: CORRELATIONS WITH CLINICAL SYMPTOMS AND INFLAMMATION INDICES

CORRELATION BETWEEN MICROBIAL MARKERS AND FAECAL CALPROTECTIN IN IBD PATIENTS
CORRELATION BETWEEN MICROBIAL MARKERS AND FAECAL CALPROTECTIN IN IBD PATIENTS

SUBOPTIMAL VACCINATION ADHERENCE IN MOTHERS WITH INFLAMMATORY BOWEL DISEASE AND THEIR BIOLOGIC EXPOSED INFANTS
SUBOPTIMAL VACCINATION ADHERENCE IN MOTHERS WITH INFLAMMATORY BOWEL DISEASE AND THEIR BIOLOGIC EXPOSED INFANTS

Item 181 - 200 / 558
1 2 3 4 5 6 7 8 9
10
11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28